ROYAL LONDON ASSET MANAGEMENT LTD

Position in JNJ — Johnson & Johnson

CIK 863748 UNITED KINGDOM, X0

Back to JNJ Full portfolio

Position in JNJ

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$293,985,543

+$57,799,717 QoQ

Shares Held

1,202,690

+5.4% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.63%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

ROYAL LONDON ASSET MANAGEMENT LTD holds $3,896,027,978 across 10 Drug Manufacturers - General names. JNJ ranks #4 (7.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	10,299,563	$2,031,279,814
2	LLY	ELI LILLY & Co	656,585	$603,907,185
3	MRK	Merck & Co., Inc.	2,896,154	$348,378,364
4	JNJ	Johnson & Johnson This page	1,202,690	$293,985,543
5	ABBV	AbbVie Inc.	1,351,717	$293,984,930
6	AMGN	Amgen Inc	281,362	$98,997,219
7	GILD	Gilead Sciences, Inc.	571,333	$79,626,680
8	PFE	Pfizer Inc	2,823,465	$79,282,897

All Filings in JNJ

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$293,985,543	1,202,690	+5.4%	Shares	Sole	2026-05-01
2025-12-31	$236,185,826	1,141,270	+3.1%	Shares	Sole	2026-02-13
2025-09-30	$205,332,995	1,107,394	+16.6%	Shares	Sole	2025-11-13
2025-06-30	$145,130,677	950,119	-41.3%	Shares	Sole	2025-08-14
2025-03-31	$268,654,829	1,619,964	-0.4%	Shares	Sole	2025-05-13
2024-12-31	$235,269,551	1,626,812	+0.0%	Shares	Sole	2025-02-11
2024-09-30	$263,638,397	1,626,795	+2.0%	Shares	Sole	2024-11-14
2024-06-30	$233,192,579	1,595,461	-6.0%	Shares	Sole	2024-08-07
2024-03-31	$268,375,504	1,696,539	+4.8%	Shares	Sole	2024-05-14
2023-12-31	$253,855,947	1,619,599	+3.4%	Shares	Sole	2024-03-01
2023-09-30	$243,979,727	1,566,483	-7.0%	Shares	Sole	2023-11-14
2023-06-30	$278,707,707	1,683,831	+21.5%	Shares	Sole	2023-08-11
2023-03-31	$214,859,915	1,386,193	+13.9%	Shares	Sole	2023-05-15
2022-12-31	$214,895,784	1,216,506	+2.3%	Shares	Sole	2023-02-09
2022-09-30	$194,338,120	1,189,631	-4.9%	Shares	Sole	2022-11-14
2022-06-30	$221,936,492	1,250,276	-0.5%	Shares	Sole	2022-09-06
2022-03-31	$222,810,188	1,257,181	+3.9%	Shares	Sole	2022-09-06
2021-12-31	$207,020,360	1,210,150	-4.7%	Shares	Sole	2022-10-18
2021-09-30	$205,166,047	1,270,378	-5.7%	Shares	Sole	2022-10-18
2021-06-30	$221,935,256	1,347,185	-6.4%	Shares	Sole	2022-10-18
2021-03-31	$236,619,461	1,439,729	-10.5%	Shares	Sole	2022-10-17
2020-12-31	$253,290,047	1,609,417	-0.1%	Shares	Sole	2021-01-29
2020-09-30	$239,791,785	1,610,638	+10.6%	Shares	Sole	2020-11-04
2020-06-30	$204,810,578	1,456,379	-3.9%	Shares	Sole	2020-07-31
2020-03-31	$198,729,744	1,515,517	—	Shares	Sole	2020-05-01
No filing history on record for this holder in this stock.